Laura Brege is EVP & Corporate Affairs at ONYX PHARMACEUTICALS INC (ONXX). They have made 12 open-market trades across 4 companies since 2007, most recently 2026-06-10.
CIK 0001365619
2 open-market purchases totalling $125K since 2019, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MIRM | SELL | 2025-09-11 | 2025-09-12 | $74.40 | $2.5M | +0.2% | -2.7% | -11.4% |
| ACAD | SELL | 2025-06-04 | 2025-06-05 | $21.78 | $629K | +5.9% | -3.0% | +19.5% |
| PCRX | BUY | 2024-08-16 | 2024-08-19 | $12.81 | $13K | +11.7% | +6.5% | +21.0% |
| ACAD | SELL · 10b5-1 | 2023-06-12 | 2023-06-14 | $24.87 | $112K | +0.3% | +33.3% | +8.2% |
| PCRX | SELL · 10b5-1 | 2023-06-05 | 2023-06-07 | $38.74 | $23K | +9.4% | +1.4% | -7.0% |
| PCRX | SELL · 10b5-1 | 2023-04-03 | 2023-04-05 | $40.72 | $285K | +5.3% | +3.9% | -6.0% |
| ACAD | SELL | 2023-01-12 | 2023-01-17 | $18.25 | $228K | +2.5% | +3.3% | +6.9% |
| PCRX | SELL | 2020-11-16 | 2020-11-17 | $65.95 | $791K | -5.8% | -6.4% | +15.5% |
| PCRX | SELL | 2020-06-05 | 2020-06-08 | $48.70 | $102K | -6.4% | +18.8% | +26.3% |
| ACAD | SELL | 2020-01-07 | 2020-01-08 | $42.19 | $422K | -2.3% | -6.2% | -6.1% |
| MIRM | BUY | 2019-09-10 | 2019-09-12 | $11.22 | $112K | -9.7% | -15.7% | -13.0% |
| ACAD | SELL | 2019-01-09 | 2019-01-11 | $20.00 | $200K | +4.2% | +3.5% | +25.3% |
| ACAD | SELL | 2018-01-02 | 2018-01-04 | $30.06 | $752K | -2.2% | -6.8% | -22.6% |
| PCRX | SELL · 10b5-1 | 2016-06-06 | 2016-06-08 | $46.95 | $47K | -17.7% | -21.9% | -12.5% |
| ACAD | SELL · 10b5-1 | 2015-02-11 | 2015-02-13 | $33.63 | $336K | -33.1% | +0.1% | +0.1% |
| ACAD | SELL · 10b5-1 | 2014-09-15 | 2014-09-16 | $28.07 | $281K | -33.1% | +0.1% | +0.1% |
| PCRX | SELL · 10b5-1 | 2014-05-09 | 2014-05-09 | $73.85 | $738K | -18.1% | +0.8% | +0.8% |
| ACAD | SELL · 10b5-1 | 2014-04-04 | 2014-04-04 | $22.54 | $322K | -33.1% | +0.1% | +0.1% |
| ACAD | SELL · 10b5-1 | 2014-01-15 | 2014-01-17 | $24.18 | $242K | -33.1% | +0.1% | +0.1% |
| ACAD | SELL · 10b5-1 | 2013-12-10 | 2013-12-12 | $23.41 | $1.0M | -33.1% | +0.1% | +0.1% |
| ACAD | SELL · 10b5-1 | 2013-10-10 | 2013-10-11 | $21.63 | $216K | -33.1% | +0.1% | +0.1% |
| ACAD | SELL · 10b5-1 | 2013-09-10 | 2013-09-12 | $22.80 | $1.1M | -33.1% | +0.1% | +0.1% |
| ONXX | SELL · 10b5-1 | 2011-10-14 | 2011-10-17 | $36.01 | $360K | N/A | N/A | N/A |
| ONXX | SELL · 10b5-1 | 2011-07-14 | 2011-07-14 | $35.00 | $350K | N/A | N/A | N/A |
| ONXX | SELL · 10b5-1 | 2011-04-26 | 2011-04-27 | $35.00 | $350K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.